Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Disc Medicine Inc 321 Arsenal Street Suite 101 Watertown MA 02472 USA

www.discmedicine.com Employees: 84 P: 617-674-9274

Sector:

Medical

Description:

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

Key Statistics

Overview:

Market Capitalization, $K 3,036,233
Enterprise Value, $K 2,872,123
Shares Outstanding, K 37,750
Annual Sales, $ 0 K
Annual Net Income, $ -109,360 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -62,320 K
EBIT, $ -203,610 K
EBITDA, $ -208,760 K
60-Month Beta 0.87
% of Insider Shareholders 3.64%
% of Institutional Shareholders 83.70%
Float, K 36,376
% Float 96.36%
Short Interest 2,587
Short Float 6.85%
Short Volume Ratio 0.75

Growth:

1-Year Return 23.31%
3-Year Return 304.37%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.77 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -5.35
EPS Growth vs. Prev Qtr -12.03%
EPS Growth vs. Prev Year -98.88%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/30/22

IRON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.61%
Return-on-Assets % -28.96%
Profit Margin % 0.00%
Debt/Equity 0.05
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.87
Book Value/Share 16.38
Interest Coverage -190.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar